FM Stewart - Concepedia

Author

FM Stewart

University of Virginia

Also Known As

FM Stewart

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Virginia University of Massachusetts Chan Medical School

About

FM Stewart is an author at University of Virginia specializing in hematology, medicine, and regenerative medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	273
2	Public Health	1	1	227
3	Blood Transplantation	1	1	26
4	Immunology	1	1	20
5	Marrow Transplantation	1	1	26

FM Stewart

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation Michele Cottler‐Fox, J. O’Shaughnessy, S Doren, Blood	1995	478
Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice [see comments] FM Stewart, RB Crittenden, PA Lowry, Blood	1993	305
Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units KK Ballen, Meredith Wilson, Joanne Wuu, Bone Marrow Transplantation Postpartum HemorrhageHematologyPediatricsPregnancyMaternal Health	2001	227
Detection of a human CFC with a high proliferative potential IK McNiece, FM Stewart, D. M. Deacon, Blood	1989	125
Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation FM Stewart, D Temeles, Philip Lowry, Blood	1993	29
Successful autologous bone marrow transplant without the use of blood product support KK Ballen, PA Ford, Heidi Waitkus, Bone Marrow Transplantation Regenerative MedicineTranslational MedicineBlood Product SupportTransplantationMarrow Transplantation	2000	26
Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation FM Stewart, D Temeles, Philip Lowry, Blood	1993	25
Granulocyte–macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome H A Rossi, Joanne A. O’Donnell, F Sarcinelli, Leukemia Hematological MalignancyElderly PatientsGranulocyteImmunologyHematology	2002	20

Page 1